Amitell Capital Pte Ltd Trims Stock Position in Tenet Healthcare Corporation $THC

Amitell Capital Pte Ltd reduced its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 21.5% during the fourth quarter, Holdings Channel reports. The institutional investor owned 35,008 shares of the company’s stock after selling 9,584 shares during the quarter. Tenet Healthcare comprises 7.8% of Amitell Capital Pte Ltd’s portfolio, making the stock its 5th biggest holding. Amitell Capital Pte Ltd’s holdings in Tenet Healthcare were worth $6,957,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Caption Management LLC purchased a new stake in Tenet Healthcare in the third quarter worth about $5,650,000. Eminence Capital LP purchased a new stake in Tenet Healthcare in the third quarter worth about $225,263,000. Hillsdale Investment Management Inc. lifted its holdings in Tenet Healthcare by 31.0% in the third quarter. Hillsdale Investment Management Inc. now owns 22,800 shares of the company’s stock worth $4,629,000 after buying an additional 5,400 shares during the period. GenTrust LLC purchased a new stake in Tenet Healthcare in the third quarter worth about $895,000. Finally, Sirios Capital Management L P lifted its holdings in Tenet Healthcare by 100.9% in the third quarter. Sirios Capital Management L P now owns 71,566 shares of the company’s stock worth $14,531,000 after buying an additional 35,947 shares during the period. 95.44% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Tenet Healthcare news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the sale, the director owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. The trade was a 25.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total transaction of $532,050.00. Following the completion of the sale, the director directly owned 24,805 shares of the company’s stock, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.97% of the company’s stock.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $173.54 on Friday. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The firm has a market cap of $14.95 billion, a P/E ratio of 9.02, a PEG ratio of 1.36 and a beta of 1.28. The company has a 50 day moving average of $184.25 and a 200 day moving average of $200.12. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter in the previous year, the firm posted $4.36 EPS. The firm’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have commented on THC. Leerink Partners raised their price objective on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Stephens lowered their target price on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Finally, Royal Bank Of Canada lowered their target price on shares of Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.